|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
affects activity decreases activity increases expression multiple interactions |
ISO |
chrysin affects the activity of ABCB1 protein chrysin results in decreased activity of ABCB1 protein chrysin results in increased expression of ABCB1 protein [chrysin results in decreased activity of ABCB1 protein] which results in decreased export of Topotecan |
CTD |
PMID:15796199 PMID:20457140 PMID:27996361 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
multiple interactions |
ISO |
ABCC1 protein affects the reaction [chrysin results in increased transport of Glutathione] |
CTD |
PMID:21856323 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
multiple interactions increases expression decreases activity |
ISO |
[chrysin results in decreased activity of ABCC2 protein] which results in decreased export of Topotecan; chrysin inhibits the reaction [ABCC2 protein affects the export of ochratoxin A] chrysin results in increased expression of ABCC2 protein |
CTD |
PMID:15955639 PMID:20457140 |
|
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
multiple interactions |
ISO |
ABCC3 protein affects the reaction [chrysin results in increased transport of Glutathione] |
CTD |
PMID:21856323 |
|
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
|
|
G |
Abcc5 |
ATP binding cassette subfamily C member 5 |
multiple interactions decreases expression |
ISO |
ABCC5 protein affects the reaction [chrysin results in increased transport of Glutathione] chrysin results in decreased expression of ABCC5 mRNA; chrysin results in decreased expression of ABCC5 protein |
CTD |
PMID:21856323 PMID:23994249 |
|
NCBI chr11:80,473,809...80,567,257
Ensembl chr11:80,473,872...80,567,253
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
multiple interactions decreases activity decreases expression increases expression |
ISO EXP |
[chrysin results in decreased activity of ABCG2 protein] which results in decreased export of Topotecan; chrysin inhibits the reaction [ABCG2 protein results in increased secretion of Mitoxantrone]; chrysin inhibits the reaction [ABCG2 protein results in increased transport of Nitrofurantoin] chrysin inhibits the reaction [ABCG2 protein affects the transport of Nitrofurantoin] chrysin results in decreased expression of ABCG2 mRNA chrysin results in increased expression of ABCG2 mRNA; chrysin results in increased expression of ABCG2 protein |
CTD |
PMID:17077187 PMID:17093006 PMID:19732493 PMID:20457140 PMID:20816778 |
|
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions |
ISO |
chrysin inhibits the reaction [Aluminum Chloride results in increased activity of ACHE protein] |
CTD |
PMID:34774662 |
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
multiple interactions |
ISO |
chrysin inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 mRNA] |
CTD |
PMID:26297989 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
increases expression |
ISO |
chrysin results in increased expression of ADIPOQ protein |
CTD |
PMID:30445784 |
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Afp |
alpha-fetoprotein |
affects binding |
EXP |
chrysin binds to AFP protein |
CTD |
PMID:23013281 PMID:25349334 |
|
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
|
|
G |
Ahr |
aryl hydrocarbon receptor |
affects activity multiple interactions |
ISO EXP |
chrysin affects the activity of AHR protein [chrysin co-treated with Methylcholanthrene] affects the activity of AHR protein; [chrysin co-treated with Tetrachlorodibenzodioxin] affects the activity of AHR protein; chrysin binds to and results in increased activity of AHR protein; chrysin inhibits the reaction [AHR protein binds to CYP1A1 promoter]; chrysin inhibits the reaction [AHR protein binds to UGT1A1 promoter]; chrysin inhibits the reaction [Tetrachlorodibenzodioxin binds to AHR protein]; chrysin promotes the reaction [AHR protein binds to CYP1A1 promoter] |
CTD |
PMID:14644660 PMID:16972788 PMID:17256720 PMID:19286049 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Akr1b10 |
aldo-keto reductase family 1 member B10 |
decreases expression |
ISO |
chrysin results in decreased expression of AKR1B10 mRNA; chrysin results in decreased expression of AKR1B10 protein |
CTD |
PMID:23994249 |
|
NCBI chr 4:63,038,459...63,060,336
Ensembl chr 4:63,040,169...63,053,852
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions decreases phosphorylation |
ISO |
BCL2 protein inhibits the reaction [chrysin results in decreased phosphorylation of and results in decreased activity of AKT1 protein]; chrysin inhibits the reaction [AKT1 protein results in increased expression of MMP10 protein]; chrysin inhibits the reaction [AKT1 protein results in increased expression of SNAI1 protein]; chrysin results in decreased phosphorylation of and results in decreased activity of AKT1 protein chrysin results in decreased phosphorylation of AKT1 protein |
CTD |
PMID:16215670 PMID:18455702 PMID:24122885 PMID:30578657 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Alb |
albumin |
multiple interactions |
EXP |
chrysin inhibits the reaction [Acetaminophen results in decreased expression of ALB protein] |
CTD |
PMID:30794797 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Apob |
apolipoprotein B |
multiple interactions |
ISO |
chrysin inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of APOB mRNA]; chrysin inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of APOB protein] |
CTD |
PMID:32220030 |
|
NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497
|
|
G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
multiple interactions |
ISO |
chrysin promotes the reaction [ARNT protein binds to CYP1A1 promoter] |
CTD |
PMID:16972788 |
|
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
|
|
G |
Arrb2 |
arrestin, beta 2 |
multiple interactions |
EXP |
chrysin inhibits the reaction [Diethylnitrosamine results in increased expression of ARRB2 mRNA]; chrysin inhibits the reaction [Diethylnitrosamine results in increased expression of ARRB2 protein] |
CTD |
PMID:21167192 |
|
NCBI chr10:55,146,887...55,154,854
Ensembl chr10:55,146,818...55,154,850
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
EXP ISO |
chrysin inhibits the reaction [Isoniazid results in increased expression of BAX protein]; chrysin inhibits the reaction [Testosterone results in decreased expression of BAX mRNA]; chrysin promotes the reaction [Diethylnitrosamine results in increased expression of BAX protein] [Cisplatin co-treated with chrysin] results in increased expression of BAX protein |
CTD |
PMID:21167192 PMID:25770930 PMID:29247772 PMID:33121995 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bche |
butyrylcholinesterase |
multiple interactions |
ISO |
chrysin inhibits the reaction [Aluminum Chloride results in increased activity of BCHE protein] |
CTD |
PMID:34774662 |
|
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases response to substance |
ISO EXP |
BCL2 protein inhibits the reaction [chrysin results in decreased expression of XIAP protein]; BCL2 protein inhibits the reaction [chrysin results in decreased phosphorylation of and results in decreased activity of AKT1 protein]; BCL2 protein inhibits the reaction [chrysin results in increased cleavage of and results in increased activity of CASP3 protein]; BCL2 protein inhibits the reaction [chrysin results in increased degradation of PLCG1 protein]; chrysin inhibits the reaction [Cisplatin results in increased expression of BCL2 protein] chrysin inhibits the reaction [Testosterone results in increased expression of BCL2 mRNA] BCL2 protein results in decreased susceptibility to chrysin |
CTD |
PMID:16215670 PMID:25770930 PMID:29247772 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
multiple interactions |
EXP |
chrysin inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2L1 mRNA]; chrysin inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2L1 protein] |
CTD |
PMID:21167192 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
increases expression multiple interactions |
ISO |
chrysin results in increased expression of BDNF protein chrysin inhibits the reaction [Oxidopamine results in decreased expression of BDNF protein] |
CTD |
PMID:29054324 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Casp1 |
caspase 1 |
multiple interactions |
ISO |
chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased activity of CASP1 protein] |
CTD |
PMID:21515303 |
|
NCBI chr 8:2,587,812...2,597,403
Ensembl chr 8:2,587,831...2,597,383
|
|
G |
Casp3 |
caspase 3 |
multiple interactions increases cleavage |
ISO EXP |
[Cisplatin co-treated with chrysin] results in increased cleavage of CASP3 protein; BCL2 protein inhibits the reaction [chrysin results in increased cleavage of and results in increased activity of CASP3 protein]; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[Cisplatin co-treated with chrysin] results in increased cleavage of CASP3 protein]; chrysin inhibits the reaction [Topotecan results in increased activity of CASP3 protein]; chrysin promotes the reaction [TNFSF10 protein results in increased degradation of CASP3 protein]; chrysin results in increased cleavage of and results in increased activity of CASP3 protein chrysin results in increased cleavage of CASP3 protein [Diethylnitrosamine co-treated with chrysin] results in increased expression of CASP3 protein; chrysin inhibits the reaction [Acetaminophen results in increased activity of CASP3 protein]; chrysin inhibits the reaction [Colistin results in increased expression of CASP3 protein]; chrysin inhibits the reaction [Freund's Adjuvant results in increased activity of CASP3 protein]; chrysin inhibits the reaction [Testosterone results in decreased cleavage of CASP3 protein]; chrysin inhibits the reaction [Thioacetamide results in increased expression of CASP3 protein] |
CTD |
PMID:16215670 PMID:18331776 PMID:19397994 PMID:20457140 PMID:21167192 PMID:21195158 PMID:24932515 PMID:25770930 PMID:28682524 PMID:29247772 PMID:30273961 PMID:30500344 More...
|
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
multiple interactions increases cleavage |
ISO |
[Cisplatin co-treated with chrysin] results in increased cleavage of CASP8 protein; chrysin inhibits the reaction [Topotecan results in increased activity of CASP8 protein]; chrysin promotes the reaction [TNFSF10 protein results in increased degradation of CASP8 protein] chrysin results in increased cleavage of CASP8 protein |
CTD |
PMID:20457140 PMID:21195158 PMID:25770930 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
increases cleavage multiple interactions |
ISO |
chrysin results in increased cleavage of CASP9 protein [Cisplatin co-treated with chrysin] results in increased cleavage of CASP9 protein |
CTD |
PMID:18331776 PMID:25770930 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions decreases activity |
EXP ISO |
chrysin inhibits the reaction [Acetaminophen results in decreased activity of CAT protein]; chrysin inhibits the reaction [Colistin results in decreased activity of CAT protein]; chrysin inhibits the reaction [ferric nitrilotriacetate results in decreased activity of CAT protein]; chrysin inhibits the reaction [Isoniazid results in decreased activity of CAT protein]; chrysin inhibits the reaction [Testosterone results in decreased activity of CAT protein] chrysin inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased activity of CAT protein]; chrysin inhibits the reaction [Aluminum Chloride results in decreased activity of CAT protein] chrysin results in decreased activity of CAT protein |
CTD |
PMID:10647909 PMID:23194824 PMID:28682524 PMID:29247772 PMID:30273961 PMID:32220030 PMID:33121995 PMID:34774662 More...
|
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccnb1 |
cyclin B1 |
decreases expression |
ISO |
chrysin results in decreased expression of CCNB1 mRNA; chrysin results in decreased expression of CCNB1 protein |
CTD |
PMID:18331776 PMID:19397994 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Cdh1 |
cadherin 1 |
increases expression |
ISO |
chrysin results in increased expression of CDH1 protein |
CTD |
PMID:24122885 PMID:30578657 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdh2 |
cadherin 2 |
decreases expression |
ISO |
chrysin results in decreased expression of CDH2 protein |
CTD |
PMID:30578657 |
|
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
increases expression multiple interactions |
ISO EXP |
chrysin results in increased expression of CDKN1A mRNA; chrysin results in increased expression of CDKN1A protein chrysin inhibits the reaction [Testosterone results in decreased expression of CDKN1A mRNA] |
CTD |
PMID:19397994 PMID:29247772 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn2c |
cyclin-dependent kinase inhibitor 2C |
decreases expression |
ISO |
chrysin results in decreased expression of CDKN2C mRNA |
CTD |
PMID:18331776 |
|
NCBI chr 5:124,411,123...124,416,278
Ensembl chr 5:124,411,124...124,416,278
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
increases expression |
ISO |
chrysin results in increased expression of CEBPA protein |
CTD |
PMID:30445784 |
|
NCBI chr 1:87,759,631...87,762,303
Ensembl chr 1:87,759,433...87,762,412
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions |
ISO |
chrysin inhibits the reaction [Topotecan results in increased cleavage of CTNNB1 protein] |
CTD |
PMID:20457140 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
multiple interactions |
ISO |
chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA]; chrysin inhibits the reaction [Poly I-C results in increased expression of CXCL10 mRNA] |
CTD |
PMID:19426678 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
decreases activity multiple interactions |
ISO |
chrysin results in decreased activity of CYP19A1 protein chrysin binds to and results in decreased activity of CYP19A1 protein |
CTD |
PMID:9435150 PMID:10403137 PMID:15319488 |
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions increases oxidation increases expression increases metabolic processing decreases activity increases activity |
ISO |
[CYP1A1 protein results in increased metabolism of chrysin] which results in increased chemical synthesis of baicalein; chrysin inhibits the reaction [AHR protein binds to CYP1A1 promoter]; chrysin inhibits the reaction [CYP1A1 results in increased activity of Benzo(a)pyrene]; chrysin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein]; chrysin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA]; chrysin promotes the reaction [AHR protein binds to CYP1A1 promoter]; chrysin promotes the reaction [ARNT protein binds to CYP1A1 promoter]; chrysin promotes the reaction [ESR1 protein binds to CYP1A1 promoter] CYP1A1 protein results in increased oxidation of chrysin chrysin results in increased expression of CYP1A1 mRNA chrysin promotes the reaction [beta-Naphthoflavone results in increased expression of CYP1A1 mRNA] chrysin results in increased expression of CYP1A1 mRNA; chrysin results in increased expression of CYP1A1 protein chrysin results in decreased activity of CYP1A1 protein chrysin results in increased activity of CYP1A1 protein |
CTD |
PMID:11752233 PMID:16972788 PMID:17012224 PMID:17256720 PMID:19666078 PMID:19766177 PMID:20816778 PMID:20930378 PMID:21053930 PMID:21482471 PMID:30964977 More...
|
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases metabolic processing increases oxidation multiple interactions decreases activity |
ISO |
CYP1A2 protein results in increased metabolism of chrysin CYP1A2 protein results in increased oxidation of chrysin [CYP1A2 protein results in increased metabolism of chrysin] which results in increased chemical synthesis of baicalein chrysin results in decreased activity of CYP1A2 protein |
CTD |
PMID:19666078 PMID:20806393 PMID:21053930 PMID:30964977 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
multiple interactions increases oxidation increases metabolic processing decreases activity |
ISO |
[CYP1B1 protein results in increased metabolism of chrysin] which results in increased chemical synthesis of baicalein; chrysin binds to and results in decreased activity of CYP1B1 protein CYP1B1 protein alternative form results in increased oxidation of chrysin chrysin results in decreased activity of CYP1B1 protein |
CTD |
PMID:19666078 PMID:21053930 PMID:21482471 PMID:30964977 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Cyp2a1 |
cytochrome P450, family 2, subfamily a, polypeptide 1 |
increases oxidation |
ISO |
CYP2A13 protein results in increased oxidation of chrysin |
CTD |
PMID:30964977 |
|
NCBI chr 1:82,231,611...82,244,887
Ensembl chr 1:82,231,611...82,244,887
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
increases expression multiple interactions |
ISO |
chrysin results in increased expression of CYP2B6 mRNA chrysin results in increased expression of CYP2B10 mRNA NR1I3 gene mutant form inhibits the reaction [chrysin results in increased expression of CYP2B10 mRNA] |
CTD |
PMID:25625231 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases activity multiple interactions |
ISO |
chrysin results in increased activity of CYP3A4 protein [[chrysin results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam] which results in increased chemical synthesis of 1-hydroxymethylmidazolam; [chrysin results in increased activity of CYP3A4 protein] which results in increased metabolism of Midazolam; chrysin binds to and results in decreased activity of CYP3A4 protein; chrysin inhibits the reaction [Calcitriol results in increased activity of CYP3A4 protein] |
CTD |
PMID:19766177 PMID:21053930 PMID:31756459 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Edn1 |
endothelin 1 |
increases expression |
ISO |
chrysin results in increased expression of EDN1 mRNA |
CTD |
PMID:18457675 |
|
NCBI chr17:22,454,924...22,460,812
Ensembl chr17:22,454,420...22,460,885
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
ISO |
chrysin inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein]; chrysin inhibits the reaction [EGF protein results in increased phosphorylation of ELK1 protein] |
CTD |
PMID:25625231 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions |
ISO |
chrysin inhibits the reaction [EGF protein results in increased phosphorylation of EGFR protein] |
CTD |
PMID:25625231 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Elk1 |
ETS transcription factor ELK1 |
multiple interactions |
ISO |
chrysin inhibits the reaction [EGF protein results in increased phosphorylation of ELK1 protein] |
CTD |
PMID:25625231 |
|
NCBI chr X:1,138,826...1,155,713
Ensembl chr X:1,139,756...1,155,713
|
|
G |
Epo |
erythropoietin |
increases expression |
ISO |
chrysin results in increased expression of EPO mRNA |
CTD |
PMID:37348668 |
|
NCBI chr12:19,204,258...19,207,948
Ensembl chr12:19,204,508...19,207,946
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
ISO |
chrysin binds to and results in increased activity of ESR1 protein; chrysin promotes the reaction [ESR1 protein binds to CYP1A1 promoter]; chrysin promotes the reaction [ESR1 protein binds to TFF1 promoter] |
CTD |
PMID:9751507 PMID:16972788 PMID:29162470 PMID:33049310 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
affects binding multiple interactions |
ISO |
chrysin binds to ESR2 protein chrysin binds to and results in increased activity of ESR2 protein |
CTD |
PMID:9751507 PMID:12224631 PMID:33049310 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Fads2 |
fatty acid desaturase 2 |
decreases expression |
ISO |
chrysin results in decreased expression of FADS2 mRNA |
CTD |
PMID:20816778 |
|
NCBI chr 1:206,707,384...206,747,333
Ensembl chr 1:206,708,783...206,748,789
|
|
G |
Faslg |
Fas ligand |
multiple interactions |
EXP |
chrysin inhibits the reaction [Freund's Adjuvant results in increased expression of FASLG mRNA] |
CTD |
PMID:24932515 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fbp1 |
fructose-bisphosphatase 1 |
decreases expression |
ISO |
chrysin results in decreased expression of FBP1 mRNA |
CTD |
PMID:18331776 |
|
NCBI chr17:2,207,271...2,230,076
Ensembl chr17:2,208,031...2,230,071
|
|
G |
Fn1 |
fibronectin 1 |
increases expression |
ISO |
chrysin results in increased expression of FN1 protein |
CTD |
PMID:26408079 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
chrysin inhibits the reaction [TNF protein results in increased activity of [FOS protein binds to JUN protein]] |
CTD |
PMID:15322261 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Foxp3 |
forkhead box P3 |
multiple interactions |
ISO |
chrysin inhibits the reaction [Diazinon results in decreased expression of FOXP3 mRNA] |
CTD |
PMID:36114367 |
|
NCBI chr X:14,908,494...14,924,994
Ensembl chr X:14,908,494...14,923,838
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
multiple interactions |
EXP |
chrysin inhibits the reaction [Freund's Adjuvant results in increased expression of FSHB protein] |
CTD |
PMID:24932515 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
Gadd45b |
growth arrest and DNA-damage-inducible, beta |
increases expression |
ISO |
chrysin results in increased expression of GADD45B mRNA; chrysin results in increased expression of GADD45B protein |
CTD |
PMID:18331776 |
|
NCBI chr 7:8,778,004...8,780,306
Ensembl chr 7:8,778,007...8,780,046
|
|
G |
Gata3 |
GATA binding protein 3 |
multiple interactions |
ISO |
chrysin inhibits the reaction [Diazinon results in increased expression of GATA3 mRNA] |
CTD |
PMID:36114367 |
|
NCBI chr17:68,643,760...68,666,000
Ensembl chr17:68,643,873...68,665,391
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
multiple interactions increases expression |
EXP |
[Buthionine Sulfoximine results in decreased activity of [GCLC protein binds to GCLM protein]] inhibits the reaction [chrysin inhibits the reaction [tert-Butylhydroperoxide results in increased chemical synthesis of Reactive Oxygen Species]]; [chrysin results in increased expression of GCLC mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide; chrysin inhibits the reaction [Isoniazid results in increased expression of GCLC mRNA]; MAPK1 protein affects the reaction [chrysin results in increased expression of GCLC protein]; NFE2L2 protein affects the reaction [chrysin results in increased expression of GCLC protein] chrysin results in increased expression of GCLC mRNA; chrysin results in increased expression of GCLC protein |
CTD |
PMID:22864849 PMID:33121995 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gclm |
glutamate cysteine ligase, modifier subunit |
multiple interactions increases expression |
EXP |
[Buthionine Sulfoximine results in decreased activity of [GCLC protein binds to GCLM protein]] inhibits the reaction [chrysin inhibits the reaction [tert-Butylhydroperoxide results in increased chemical synthesis of Reactive Oxygen Species]]; [chrysin results in increased expression of GCLM mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide; chrysin inhibits the reaction [Isoniazid results in increased expression of GCLM mRNA]; MAPK1 protein affects the reaction [chrysin results in increased expression of GCLM protein]; NFE2L2 protein affects the reaction [chrysin results in increased expression of GCLM protein] chrysin results in increased expression of GCLM mRNA; chrysin results in increased expression of GCLM protein |
CTD |
PMID:22864849 PMID:33121995 |
|
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
|
|
G |
Gdnf |
glial cell derived neurotrophic factor |
multiple interactions |
ISO |
chrysin inhibits the reaction [Oxidopamine results in decreased expression of GDNF protein] |
CTD |
PMID:29054324 |
|
NCBI chr 2:56,894,022...56,919,935
Ensembl chr 2:56,895,010...56,917,209
|
|
G |
Gfap |
glial fibrillary acidic protein |
multiple interactions |
EXP |
chrysin inhibits the reaction [Isoniazid results in increased expression of GFAP mRNA]; chrysin inhibits the reaction [Isoniazid results in increased expression of GFAP protein] |
CTD |
PMID:33121995 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
EXP |
chrysin inhibits the reaction [Acetaminophen results in increased activity of GPT protein]; chrysin inhibits the reaction [Acetaminophen results in increased expression of GPT protein] |
CTD |
PMID:28682524 PMID:30794797 PMID:31625388 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Grb2 |
growth factor receptor bound protein 2 |
decreases expression |
ISO |
chrysin results in decreased expression of GRB2 protein |
CTD |
PMID:30578657 |
|
NCBI chr10:100,881,404...100,949,193
Ensembl chr10:100,869,718...100,949,309
|
|
G |
Greb1 |
growth regulating estrogen receptor binding 1 |
multiple interactions increases expression |
ISO |
Fulvestrant inhibits the reaction [chrysin results in increased expression of GREB1 mRNA] |
CTD |
PMID:33405908 |
|
NCBI chr 6:39,440,522...39,562,364
Ensembl chr 6:39,440,504...39,581,633
|
|
G |
Gsr |
glutathione-disulfide reductase |
decreases activity |
EXP |
chrysin results in decreased activity of GSR protein |
CTD |
PMID:10647909 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
multiple interactions increases expression |
ISO |
chrysin results in decreased degradation of and results in increased expression of HIF1A protein modified form chrysin results in increased expression of HIF1A mRNA; chrysin results in increased expression of HIF1A protein |
CTD |
PMID:37348668 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions decreases expression increases expression |
EXP ISO |
[chrysin results in increased expression of HMOX1 mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide; [zinc protoporphyrin results in decreased activity of HMOX1 protein] inhibits the reaction [chrysin inhibits the reaction [tert-Butylhydroperoxide results in increased chemical synthesis of Reactive Oxygen Species]]; chrysin inhibits the reaction [Isoniazid results in increased expression of HMOX1 mRNA]; MAPK1 protein affects the reaction [chrysin results in increased expression of HMOX1 protein]; NFE2L2 protein affects the reaction [chrysin results in increased expression of HMOX1 protein] chrysin results in decreased expression of HMOX1 mRNA; chrysin results in decreased expression of HMOX1 protein chrysin results in increased expression of HMOX1 mRNA; chrysin results in increased expression of HMOX1 protein |
CTD |
PMID:22864849 PMID:23994249 PMID:33121995 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
multiple interactions |
ISO |
chrysin inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased phosphorylation of and affects the localization of HNF4A protein] chrysin inhibits the reaction [Hydrogen Peroxide results in decreased expression of HNF4A mRNA]; chrysin inhibits the reaction [Hydrogen Peroxide results in increased phosphorylation of HNF4A protein] |
CTD |
PMID:32220030 |
|
NCBI chr 3:152,186,787...152,248,320
Ensembl chr 3:152,186,787...152,248,320
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
multiple interactions |
ISO |
chrysin inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; chrysin inhibits the reaction [TNF protein results in increased expression of ICAM1 protein] |
CTD |
PMID:15322261 PMID:16987811 |
|
NCBI chr 8:19,553,063...19,565,438
Ensembl chr 8:19,553,645...19,565,438
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
chrysin inhibits the reaction [Diazinon results in decreased expression of IFNG mRNA]; chrysin inhibits the reaction [Diazinon results in decreased expression of IFNG protein]; chrysin inhibits the reaction [Oxidopamine results in increased expression of IFNG protein] |
CTD |
PMID:29054324 PMID:36114367 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Igf1 |
insulin-like growth factor 1 |
multiple interactions |
EXP |
chrysin inhibits the reaction [Testosterone results in increased expression of IGF1 mRNA] |
CTD |
PMID:29247772 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
multiple interactions |
EXP |
chrysin inhibits the reaction [Testosterone results in increased expression of IGF1R mRNA] |
CTD |
PMID:29247772 |
|
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
multiple interactions |
ISO |
chrysin inhibits the reaction [nickel chloride results in increased phosphorylation of IKBKB protein] |
CTD |
PMID:30016632 |
|
NCBI chr16:69,319,487...69,373,251
Ensembl chr16:69,319,554...69,373,250
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
EXP ISO |
chrysin inhibits the reaction [Cyclophosphamide results in increased expression of IL10 protein]; chrysin inhibits the reaction [Freund's Adjuvant results in decreased expression of IL10 protein] chrysin inhibits the reaction [nickel chloride results in increased expression of IL10 protein] chrysin inhibits the reaction [Diazinon results in increased expression of IL10 mRNA]; chrysin inhibits the reaction [Oxidopamine results in decreased expression of IL10 protein] |
CTD |
PMID:24932515 PMID:29054324 PMID:30016632 PMID:36114367 PMID:37263553 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il15 |
interleukin 15 |
decreases expression |
ISO |
chrysin results in decreased expression of IL15 mRNA |
CTD |
PMID:20816778 |
|
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
|
|
G |
Il17a |
interleukin 17A |
multiple interactions |
ISO |
chrysin inhibits the reaction [Diazinon results in increased expression of IL17A mRNA] |
CTD |
PMID:36114367 |
|
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions decreases expression |
ISO EXP |
chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL1B mRNA]; chrysin inhibits the reaction [IL1B protein results in increased phosphorylation of NFKBIA protein]; chrysin inhibits the reaction [IL1B protein results in increased secretion of CXCL8 protein]; chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; chrysin inhibits the reaction [nickel chloride results in increased expression of IL1B protein] chrysin inhibits the reaction [Oxidopamine results in increased expression of IL1B protein] chrysin inhibits the reaction [Acetaminophen results in increased expression of IL1B protein]; chrysin inhibits the reaction [Cyclophosphamide results in increased expression of IL1B protein]; chrysin inhibits the reaction [Isoniazid results in increased expression of IL1B mRNA] chrysin results in decreased expression of IL1B mRNA |
CTD |
PMID:18377686 PMID:20816778 PMID:21515303 PMID:28682524 PMID:29054324 PMID:30016632 PMID:33121995 PMID:34774662 PMID:37263553 More...
|
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il1r1 |
interleukin 1 receptor type 1 |
decreases expression |
ISO |
chrysin results in decreased expression of IL1R1 mRNA |
CTD |
PMID:20816778 |
|
NCBI chr 9:42,504,917...42,580,958
Ensembl chr 9:42,504,735...42,579,937
|
|
G |
Il4 |
interleukin 4 |
multiple interactions |
ISO |
chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL4 mRNA] chrysin inhibits the reaction [Diazinon results in increased expression of IL4 mRNA] |
CTD |
PMID:21515303 PMID:36114367 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il6 |
interleukin 6 |
multiple interactions increases expression decreases expression |
ISO EXP |
chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of IL6 mRNA]; chrysin inhibits the reaction [nickel chloride results in increased expression of IL6 protein] chrysin inhibits the reaction [Oxidopamine results in increased expression of IL6 protein] chrysin inhibits the reaction [[Diethylnitrosamine co-treated with ferric nitrilotriacetate] results in increased expression of IL6 protein]; chrysin inhibits the reaction [Cyclophosphamide results in increased expression of IL6 protein]; chrysin inhibits the reaction [Isoniazid results in increased expression of IL6 mRNA]; chrysin inhibits the reaction [Thioacetamide results in increased expression of IL6 protein] chrysin results in increased expression of IL6 mRNA chrysin results in decreased expression of IL6 mRNA |
CTD |
PMID:18457675 PMID:20816778 PMID:21515303 PMID:23194824 PMID:29054324 PMID:30016632 PMID:30500344 PMID:33121995 PMID:37263553 More...
|
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ins1 |
insulin 1 |
multiple interactions |
EXP |
2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [chrysin inhibits the reaction [Fructose results in increased expression of INS1 protein]]; chrysin inhibits the reaction [Fructose results in increased expression of INS1 protein] |
CTD |
PMID:25169908 |
|
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
|
|
G |
Irf3 |
interferon regulatory factor 3 |
multiple interactions |
ISO |
chrysin inhibits the reaction [Poly I-C results in increased expression of IRF3 mRNA] |
CTD |
PMID:19426678 |
|
NCBI chr 1:95,479,966...95,484,926
Ensembl chr 1:95,479,821...95,484,935
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions decreases phosphorylation |
ISO |
chrysin inhibits the reaction [TNF protein results in increased activity of [FOS protein binds to JUN protein]]; chrysin inhibits the reaction [TNF protein results in increased expression of JUN mRNA] chrysin results in decreased phosphorylation of JUN protein |
CTD |
PMID:15322261 PMID:30578657 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Klf4 |
KLF transcription factor 4 |
multiple interactions |
ISO |
chrysin inhibits the reaction [angiotensin II increases expression of KLF4 protein in vascular smooth muscle cells] |
RGD |
PMID:29127880 |
RGD:155230825 |
NCBI chr 5:70,278,843...70,283,751
Ensembl chr 5:70,278,972...70,283,602
|
|
G |
Lamb2 |
laminin subunit beta 2 |
increases expression |
ISO |
chrysin results in increased expression of LAMB2 protein |
CTD |
PMID:26408079 |
|
NCBI chr 8:109,178,367...109,190,552
Ensembl chr 8:109,178,409...109,190,549
|
|
G |
Lep |
leptin |
decreases expression |
ISO |
chrysin results in decreased expression of LEP protein |
CTD |
PMID:30445784 |
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Lhb |
luteinizing hormone subunit beta |
multiple interactions |
EXP |
chrysin inhibits the reaction [Freund's Adjuvant results in increased expression of LHB protein] |
CTD |
PMID:24932515 |
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
multiple interactions |
EXP |
chrysin inhibits the reaction [Acetaminophen results in increased expression of MAP1LC3B protein]; chrysin inhibits the reaction [Colistin results in increased expression of MAP1LC3B protein] |
CTD |
PMID:28682524 PMID:30273961 |
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions increases phosphorylation increases activity |
EXP ISO |
MAPK1 protein affects the reaction [chrysin results in increased expression of GCLC protein]; MAPK1 protein affects the reaction [chrysin results in increased expression of GCLM protein]; MAPK1 protein affects the reaction [chrysin results in increased expression of HMOX1 protein] [chrysin co-treated with Cisplatin] results in increased phosphorylation of MAPK1 protein chrysin results in increased phosphorylation of MAPK1 protein chrysin results in increased activity of MAPK1 protein |
CTD |
PMID:22864849 PMID:25770930 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
multiple interactions |
EXP |
chrysin inhibits the reaction [Cyclophosphamide results in increased expression of MAPK14 protein] |
CTD |
PMID:37263553 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions increases phosphorylation |
ISO |
[chrysin co-treated with Cisplatin] results in increased phosphorylation of MAPK3 protein chrysin results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:25770930 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mmp1 |
matrix metallopeptidase 1 |
decreases expression |
ISO |
chrysin results in decreased expression of MMP1 protein |
CTD |
PMID:30578657 |
|
NCBI chr 8:4,658,588...4,679,099
Ensembl chr 8:4,658,588...4,679,097
|
|
G |
Mmp10 |
matrix metallopeptidase 10 |
multiple interactions decreases expression |
ISO |
chrysin inhibits the reaction [AKT1 protein results in increased expression of MMP10 protein] chrysin results in decreased expression of MMP10 protein |
CTD |
PMID:24122885 |
|
NCBI chr 8:4,689,840...4,697,748
Ensembl chr 8:4,689,840...4,697,748
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions decreases activity |
ISO |
chrysin results in decreased expression of and results in decreased activity of MMP2 protein chrysin results in decreased activity of MMP2 protein |
CTD |
PMID:26408079 PMID:30578657 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
multiple interactions |
ISO |
chrysin inhibits the reaction [nickel chloride results in increased expression of and results in increased activity of MMP9 protein] |
CTD |
PMID:30016632 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
EXP |
chrysin inhibits the reaction [Freund's Adjuvant results in increased activity of MPO protein] |
CTD |
PMID:24932515 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mybl1 |
MYB proto-oncogene like 1 |
increases expression multiple interactions |
ISO |
chrysin results in increased expression of MYBL1 mRNA Fulvestrant inhibits the reaction [chrysin results in increased expression of MYBL1 mRNA] |
CTD |
PMID:33405908 |
|
NCBI chr 5:9,582,905...9,618,179
Ensembl chr 5:9,582,934...9,618,183
|
|
G |
Myd88 |
MYD88, innate immune signal transduction adaptor |
multiple interactions |
ISO |
chrysin inhibits the reaction [nickel chloride results in increased expression of MYD88 mRNA]; chrysin inhibits the reaction [nickel chloride results in increased expression of MYD88 protein] |
CTD |
PMID:30016632 |
|
NCBI chr 8:119,074,439...119,078,508
Ensembl chr 8:119,074,437...119,079,415
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions decreases expression |
EXP ISO |
chrysin affects the localization of and results in increased activity of NFE2L2 protein; chrysin inhibits the reaction [Isoniazid results in increased expression of NFE2L2 mRNA]; NFE2L2 protein affects the reaction [chrysin results in increased expression of GCLC protein]; NFE2L2 protein affects the reaction [chrysin results in increased expression of GCLM protein]; NFE2L2 protein affects the reaction [chrysin results in increased expression of HMOX1 protein] chrysin inhibits the reaction [NFE2L2 protein results in decreased susceptibility to Doxorubicin] chrysin results in decreased expression of NFE2L2 mRNA; chrysin results in decreased expression of NFE2L2 protein |
CTD |
PMID:22864849 PMID:23994249 PMID:33121995 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
EXP |
chrysin inhibits the reaction [Isoniazid results in increased expression of NFKB1 mRNA]; chrysin inhibits the reaction [Thioacetamide results in increased expression of NFKB1 protein] |
CTD |
PMID:30500344 PMID:33121995 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
multiple interactions decreases expression |
ISO |
chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased degradation of NFKBIA protein]; chrysin inhibits the reaction [IL1B protein results in increased phosphorylation of NFKBIA protein]; chrysin inhibits the reaction [nickel chloride results in increased phosphorylation of NFKBIA protein] chrysin results in decreased expression of NFKBIA protein |
CTD |
PMID:18377686 PMID:21515303 PMID:30016632 PMID:30578657 |
|
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
|
|
G |
Ngf |
nerve growth factor |
multiple interactions |
ISO |
chrysin inhibits the reaction [Oxidopamine results in decreased expression of NGF protein] |
CTD |
PMID:29054324 |
|
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO EXP |
chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]; PPARG protein affects the reaction [chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]] chrysin inhibits the reaction [[Diethylnitrosamine co-treated with ferric nitrilotriacetate] results in increased expression of NOS2 protein]; chrysin inhibits the reaction [Cyclophosphamide results in increased expression of NOS2 protein]; chrysin inhibits the reaction [ferric nitrilotriacetate results in increased expression of NOS2 protein]; chrysin inhibits the reaction [Freund's Adjuvant results in increased expression of NOS2 protein] |
CTD |
PMID:11343698 PMID:16934226 PMID:17570322 PMID:23194824 PMID:24932515 PMID:34774662 PMID:37263553 More...
|
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nos3 |
nitric oxide synthase 3 |
multiple interactions |
EXP |
chrysin inhibits the reaction [alpha-naphthyl thiourea results in decreased expression of NOS3 mRNA] |
CTD |
PMID:30974023 |
|
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions |
EXP |
chrysin inhibits the reaction [Isoniazid results in increased expression of NQO1 mRNA] |
CTD |
PMID:33121995 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
increases expression |
ISO |
Chrysin increases expression of Nr1h3 mRNA in macrophages |
RGD |
PMID:25857322 |
RGD:401850558 |
NCBI chr 3:77,158,808...77,168,907
Ensembl chr 3:77,158,808...77,168,722
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
multiple interactions |
ISO |
chrysin inhibits the reaction [pregna-4,17-diene-3,16-dione results in decreased activity of NR1H4 protein] |
CTD |
PMID:25257666 |
|
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions |
ISO |
chrysin binds to and results in increased activity of NR1I2 protein |
CTD |
PMID:33049310 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
affects localization multiple interactions |
ISO |
chrysin affects the localization of NR1I3 protein NR1I3 gene mutant form inhibits the reaction [chrysin results in increased expression of CYP2B10 mRNA] |
CTD |
PMID:25625231 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases cleavage multiple interactions |
ISO EXP |
chrysin results in increased cleavage of PARP1 protein [Cisplatin co-treated with chrysin] results in increased cleavage of PARP1 protein; benzyloxycarbonyl-valyl-alanyl-aspartic acid analog inhibits the reaction [[Cisplatin co-treated with chrysin] results in increased cleavage of PARP1 protein] chrysin inhibits the reaction [Cyclophosphamide results in increased expression of PARP1 protein] |
CTD |
PMID:18455702 PMID:25770930 PMID:37263553 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions |
EXP |
chrysin inhibits the reaction [[Diethylnitrosamine co-treated with ferric nitrilotriacetate] results in increased expression of PCNA protein]; chrysin inhibits the reaction [Testosterone results in increased expression of PCNA protein] |
CTD |
PMID:23194824 PMID:29247772 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pgd |
phosphogluconate dehydrogenase |
decreases activity |
ISO |
chrysin results in decreased activity of PGD protein |
CTD |
PMID:25130191 |
|
NCBI chr 5:159,582,746...159,598,945
Ensembl chr 5:159,561,271...159,742,778
|
|
G |
Plau |
plasminogen activator, urokinase |
decreases expression |
ISO |
chrysin results in decreased expression of PLAU protein |
CTD |
PMID:30578657 |
|
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
|
|
G |
Plcg1 |
phospholipase C, gamma 1 |
multiple interactions increases degradation |
ISO |
BCL2 protein inhibits the reaction [chrysin results in increased degradation of PLCG1 protein] |
CTD |
PMID:16215670 |
|
NCBI chr 3:149,385,587...149,416,330
Ensembl chr 3:149,385,587...149,416,330
|
|
G |
Por |
cytochrome p450 oxidoreductase |
multiple interactions |
ISO |
[CYP2A6 protein co-treated with POR protein] results in increased oxidation of chrysin |
CTD |
PMID:30964977 |
|
NCBI chr12:20,951,058...20,999,198
Ensembl chr12:20,951,058...20,999,245
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
decreases expression |
ISO |
chrysin results in decreased expression of PPARA mRNA |
CTD |
PMID:20816778 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions |
ISO |
chrysin binds to and results in increased activity of PPARG protein; PPARG protein affects the reaction [chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]]; PPARG protein affects the reaction [chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]] |
CTD |
PMID:11343698 PMID:33049310 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Psca |
prostate stem cell antigen |
decreases expression |
ISO |
chrysin results in decreased expression of PSCA mRNA |
CTD |
PMID:18331776 |
|
NCBI chr 7:106,598,203...106,603,114
Ensembl chr 7:106,595,284...106,609,746
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
increases expression multiple interactions |
ISO EXP |
chrysin results in increased expression of PTGS2 mRNA chrysin inhibits the reaction [[Diethylnitrosamine co-treated with ferric nitrilotriacetate] results in increased expression of PTGS2 protein]; chrysin inhibits the reaction [Diethylnitrosamine results in increased expression of PTGS2 mRNA]; chrysin inhibits the reaction [ferric nitrilotriacetate results in increased expression of PTGS2 protein]; chrysin inhibits the reaction [Freund's Adjuvant results in increased expression of PTGS2 protein] chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]; PPARG protein affects the reaction [chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]] |
CTD |
PMID:11343698 PMID:18457675 PMID:21167192 PMID:23194824 PMID:24932515 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Ptk2 |
protein tyrosine kinase 2 |
decreases phosphorylation |
ISO |
chrysin results in decreased phosphorylation of PTK2 protein |
CTD |
PMID:30578657 |
|
NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
|
|
G |
Rbp4 |
retinol binding protein 4 |
decreases expression |
ISO |
chrysin results in decreased expression of RBP4 protein |
CTD |
PMID:30445784 |
|
NCBI chr 1:235,893,917...235,901,315
Ensembl chr 1:235,893,917...235,901,399
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions decreases expression increases activity |
ISO EXP |
Acetylcysteine inhibits the reaction [chrysin results in increased activity of RELA protein]; chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] affects the localization of RELA protein]; chrysin inhibits the reaction [nickel chloride affects the localization of RELA protein]; SB 203580 inhibits the reaction [chrysin results in increased activity of RELA protein] chrysin results in decreased expression of RELA protein chrysin inhibits the reaction [Oxidopamine results in increased phosphorylation of RELA protein] chrysin inhibits the reaction [[Diethylnitrosamine co-treated with ferric nitrilotriacetate] results in increased localization of RELA protein]; chrysin inhibits the reaction [Diethylnitrosamine results in increased expression of RELA mRNA]; chrysin inhibits the reaction [Diethylnitrosamine results in increased expression of RELA protein]; chrysin inhibits the reaction [Testosterone results in increased activity of RELA protein] |
CTD |
PMID:18457675 PMID:21167192 PMID:21515303 PMID:23194824 PMID:29054324 PMID:29247772 PMID:30016632 PMID:30578657 More...
|
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rhoa |
ras homolog family member A |
decreases expression |
ISO |
chrysin results in decreased expression of RHOA protein |
CTD |
PMID:30578657 |
|
NCBI chr 8:108,991,926...109,025,746
Ensembl chr 8:108,991,954...109,025,746
|
|
G |
Rorc |
RAR-related orphan receptor C |
multiple interactions |
ISO |
chrysin inhibits the reaction [Diazinon results in increased expression of RORC mRNA] |
CTD |
PMID:36114367 |
|
NCBI chr 2:182,009,707...182,034,910
Ensembl chr 2:182,009,286...182,034,907
|
|
G |
RT1-Da |
RT1 class II, locus Da |
decreases expression |
ISO |
chrysin results in decreased expression of HLA-DRA mRNA |
CTD |
PMID:20816778 |
|
NCBI chr20:4,513,464...4,518,457
Ensembl chr20:4,512,911...4,518,455
|
|
G |
S100b |
S100 calcium binding protein B |
multiple interactions |
ISO |
chrysin inhibits the reaction [Oxidopamine results in increased expression of S100B protein] |
CTD |
PMID:29054324 |
|
NCBI chr20:12,372,866...12,381,619
Ensembl chr20:12,372,881...12,394,743
|
|
G |
Sc5d |
sterol-C5-desaturase |
decreases expression |
ISO |
chrysin results in decreased expression of SC5D mRNA |
CTD |
PMID:20816778 |
|
NCBI chr 8:42,629,649...42,641,257
Ensembl chr 8:42,632,672...42,641,273
|
|
G |
Scd |
stearoyl-CoA desaturase |
decreases expression |
ISO |
chrysin results in decreased expression of SCD mRNA |
CTD |
PMID:20816778 |
|
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
|
|
G |
Sele |
selectin E |
multiple interactions |
ISO |
chrysin inhibits the reaction [TNF protein results in increased expression of SELE protein] |
CTD |
PMID:16987811 |
|
NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
|
|
G |
Sfn |
stratifin |
increases expression |
ISO |
chrysin results in increased expression of SFN mRNA; chrysin results in increased expression of SFN protein |
CTD |
PMID:18331776 |
|
NCBI chr 5:145,826,722...145,827,994
Ensembl chr 5:145,826,201...145,831,314
|
|
G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
increases expression multiple interactions |
ISO |
chrysin results in increased expression of SGK1 mRNA Fulvestrant inhibits the reaction [chrysin results in increased expression of SGK1 mRNA] |
CTD |
PMID:33405908 |
|
NCBI chr 1:22,980,257...23,098,122
Ensembl chr 1:22,980,261...23,098,283
|
|
G |
Shbg |
sex hormone binding globulin |
affects binding |
ISO |
chrysin binds to SHBG protein |
CTD |
PMID:25349334 |
|
NCBI chr10:54,332,939...54,350,409
Ensembl chr10:54,332,941...54,351,057
|
|
G |
Slc16a1 |
solute carrier family 16 member 1 |
multiple interactions |
EXP |
[chrysin results in decreased activity of SLC16A1 protein] which results in decreased uptake of Sodium Oxybate |
CTD |
PMID:17108059 |
|
NCBI chr 2:192,123,755...192,144,617
Ensembl chr 2:192,124,289...192,144,611
|
|
G |
Smad2 |
SMAD family member 2 |
multiple interactions |
ISO |
chrysin inhibits the reaction [Carbon Tetrachloride results in increased expression of SMAD2 mRNA] |
CTD |
PMID:26297989 |
|
NCBI chr18:69,849,884...69,918,926
Ensembl chr18:69,850,377...69,912,323
|
|
G |
Smad3 |
SMAD family member 3 |
multiple interactions |
ISO |
chrysin inhibits the reaction [Carbon Tetrachloride results in increased expression of SMAD3 mRNA] |
CTD |
PMID:26297989 |
|
NCBI chr 8:64,126,829...64,236,960
Ensembl chr 8:64,110,039...64,236,960
|
|
G |
Snai1 |
snail family transcriptional repressor 1 |
decreases expression multiple interactions |
ISO |
chrysin results in decreased expression of SNAI1 protein chrysin inhibits the reaction [AKT1 protein results in increased expression of SNAI1 protein] |
CTD |
PMID:24122885 PMID:30578657 |
|
NCBI chr 3:156,248,479...156,252,969
Ensembl chr 3:156,248,485...156,252,969
|
|
G |
Snai2 |
snail family transcriptional repressor 2 |
decreases expression |
ISO |
chrysin results in decreased expression of SNAI2 protein |
CTD |
PMID:24122885 |
|
NCBI chr11:86,182,788...86,186,203
Ensembl chr11:86,181,909...86,186,200
|
|
G |
Sos1 |
SOS Ras/Rac guanine nucleotide exchange factor 1 |
decreases expression |
ISO |
chrysin results in decreased expression of SOS1 protein |
CTD |
PMID:30578657 |
|
NCBI chr 6:14,533,870...14,613,348
Ensembl chr 6:14,533,360...14,611,107
|
|
G |
Star |
steroidogenic acute regulatory protein |
multiple interactions |
EXP |
chrysin inhibits the reaction [Freund's Adjuvant results in decreased expression of STAR mRNA] |
CTD |
PMID:24932515 |
|
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
multiple interactions |
EXP |
chrysin inhibits the reaction [Cyclophosphamide results in increased phosphorylation of STAT3 protein] |
CTD |
PMID:37263553 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Sult1a1 |
sulfotransferase family 1A member 1 |
increases sulfation |
ISO |
SULT1A1 protein SNP results in increased sulfation of chrysin |
CTD |
PMID:17293380 |
|
NCBI chr 1:181,272,022...181,276,750
Ensembl chr 1:181,272,023...181,275,562
|
|
G |
Sult1e1 |
sulfotransferase family 1E member 1 |
multiple interactions |
ISO |
SULT1E1 protein results in increased sulfation of and results in decreased activity of chrysin |
CTD |
PMID:17293380 |
|
NCBI chr14:20,422,324...20,439,562
Ensembl chr14:20,422,324...20,439,275
|
|
G |
Tbk1 |
TANK-binding kinase 1 |
decreases activity |
ISO |
chrysin results in decreased activity of TBK1 protein |
CTD |
PMID:19426678 |
|
NCBI chr 7:57,077,830...57,110,868
Ensembl chr 7:57,077,830...57,110,892
|
|
G |
Tbx21 |
T-box transcription factor 21 |
multiple interactions |
ISO |
chrysin inhibits the reaction [Diazinon results in decreased expression of TBX21 mRNA] |
CTD |
PMID:36114367 |
|
NCBI chr10:82,082,322...82,098,831
Ensembl chr10:82,082,322...82,098,831
|
|
G |
Tff1 |
trefoil factor 1 |
multiple interactions |
ISO |
chrysin promotes the reaction [ESR1 protein binds to TFF1 promoter] |
CTD |
PMID:16972788 |
|
NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
ISO |
chrysin inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFB1 mRNA]; chrysin inhibits the reaction [Diazinon results in increased expression of TGFB1 mRNA] |
CTD |
PMID:26297989 PMID:36114367 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Thra |
thyroid hormone receptor alpha |
multiple interactions |
ISO |
chrysin binds to and results in increased activity of THRA protein |
CTD |
PMID:33049310 |
|
NCBI chr10:83,701,885...83,729,408
Ensembl chr10:83,700,755...83,729,936
|
|
G |
Thrb |
thyroid hormone receptor beta |
multiple interactions |
ISO |
chrysin binds to and results in increased activity of THRB protein |
CTD |
PMID:33049310 |
|
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions |
ISO EXP |
chrysin inhibits the reaction [nickel chloride results in increased expression of TLR4 mRNA]; chrysin inhibits the reaction [nickel chloride results in increased expression of TLR4 protein] chrysin inhibits the reaction [Thioacetamide results in increased expression of TLR4 mRNA] |
CTD |
PMID:30016632 PMID:30500344 |
|
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions decreases expression |
ISO EXP |
chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased expression of TNF mRNA]; chrysin inhibits the reaction [[Calcimycin co-treated with Tetradecanoylphorbol Acetate] results in increased secretion of TNF protein]; chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; chrysin inhibits the reaction [nickel chloride results in increased expression of TNF protein]; chrysin inhibits the reaction [TNF protein results in increased activity of [FOS protein binds to JUN protein]]; chrysin inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]; chrysin inhibits the reaction [TNF protein results in increased expression of ICAM1 protein]; chrysin inhibits the reaction [TNF protein results in increased expression of JUN mRNA]; chrysin inhibits the reaction [TNF protein results in increased expression of SELE protein]; chrysin inhibits the reaction [TNF protein results in increased expression of VCAM1 protein] chrysin results in decreased expression of TNF protein chrysin inhibits the reaction [[Diethylnitrosamine co-treated with ferric nitrilotriacetate] results in increased expression of TNF protein]; chrysin inhibits the reaction [Acetaminophen results in increased expression of TNF protein]; chrysin inhibits the reaction [Cyclophosphamide results in increased expression of TNF protein]; chrysin inhibits the reaction [Freund's Adjuvant results in increased expression of TNF protein]; chrysin inhibits the reaction [Isoniazid results in increased expression of TNF protein]; chrysin inhibits the reaction [Thioacetamide results in increased expression of TNF protein]; Silymarin promotes the reaction [chrysin inhibits the reaction [Acetaminophen results in increased expression of TNF protein]] chrysin inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]; chrysin inhibits the reaction [Oxidopamine results in increased expression of TNF protein] |
CTD |
PMID:15322261 PMID:16934226 PMID:16987811 PMID:21515303 PMID:23194824 PMID:24932515 PMID:28682524 PMID:29054324 PMID:30016632 PMID:30445784 PMID:30500344 PMID:31625388 PMID:33121995 PMID:34774662 PMID:37263553 More...
|
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnfsf10 |
TNF superfamily member 10 |
multiple interactions increases response to substance |
ISO |
chrysin promotes the reaction [TNFSF10 protein results in increased degradation of CASP3 protein]; chrysin promotes the reaction [TNFSF10 protein results in increased degradation of CASP8 protein] chrysin results in increased susceptibility to TNFSF10 protein |
CTD |
PMID:21195158 |
|
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
|
|
G |
Tp53 |
tumor protein p53 |
increases degradation affects activity multiple interactions |
ISO EXP |
chrysin results in increased degradation of TP53 protein chrysin affects the activity of TP53 protein [Cisplatin co-treated with chrysin] affects the localization of TP53 protein; [Cisplatin co-treated with chrysin] results in increased phosphorylation of and results in increased expression of TP53 protein; chrysin results in increased phosphorylation of and affects the localization of TP53 protein; U 0126 inhibits the reaction [[Cisplatin co-treated with chrysin] affects the localization of TP53 protein]; U 0126 inhibits the reaction [[Cisplatin co-treated with chrysin] results in increased phosphorylation of TP53 protein] [Diethylnitrosamine co-treated with chrysin] results in increased expression of TP53 protein; chrysin inhibits the reaction [Diethylnitrosamine results in decreased expression of TP53 mRNA]; chrysin inhibits the reaction [Testosterone results in decreased expression of TP53 mRNA] |
CTD |
PMID:14634213 PMID:21167192 PMID:25770930 PMID:29247772 PMID:35435491 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tp53i3 |
tumor protein p53 inducible protein 3 |
increases expression |
ISO |
chrysin results in increased expression of TP53I3 mRNA; chrysin results in increased expression of TP53I3 protein |
CTD |
PMID:18331776 PMID:19397994 |
|
NCBI chr 6:27,818,327...27,825,753
|
|
G |
Tp63 |
tumor protein p63 |
increases expression |
ISO |
chrysin results in increased expression of TP63 protein |
CTD |
PMID:18331776 PMID:19397994 |
|
NCBI chr11:74,838,858...75,049,764
Ensembl chr11:74,838,859...75,049,398
|
|
G |
Tp73 |
tumor protein p73 |
increases expression |
ISO |
chrysin results in increased expression of TP73 protein |
CTD |
PMID:18331776 PMID:19397994 |
|
NCBI chr 5:164,621,377...164,703,958
Ensembl chr 5:164,621,377...164,681,128
|
|
G |
Tyr |
tyrosinase |
increases expression |
ISO |
chrysin results in increased expression of TYR mRNA |
CTD |
PMID:21071833 |
|
NCBI chr 1:141,115,036...141,210,207
Ensembl chr 1:141,115,036...141,210,207
|
|
G |
Ugt1a1 |
UDP glucuronosyltransferase family 1 member A1 |
multiple interactions affects glucuronidation increases glucuronidation increases expression |
ISO EXP |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [chrysin results in increased expression of UGT1A1 mRNA]; chrysin inhibits the reaction [AHR protein binds to UGT1A1 promoter]; chrysin promotes the reaction [UGT1A1 protein affects the glucuronidation of Bilirubin]; chrysin promotes the reaction [UGT1A1 protein affects the glucuronidation of Ethinyl Estradiol]; chrysin promotes the reaction [UGT1A1 protein results in increased glucuronidation of Bilirubin]; chrysin promotes the reaction [UGT1A1 protein results in increased glucuronidation of Quercetin]; pyrazolanthrone inhibits the reaction [chrysin results in increased expression of UGT1A1 mRNA]; SB 203580 inhibits the reaction [chrysin results in increased expression of UGT1A1 mRNA]; U 0126 inhibits the reaction [chrysin results in increased expression of UGT1A1 mRNA] UGT1A1 protein affects the glucuronidation of chrysin UGT1A1 protein results in increased glucuronidation of chrysin chrysin results in increased expression of UGT1A1; chrysin results in increased expression of UGT1A1 mRNA; chrysin results in increased expression of UGT1A1 protein |
CTD |
PMID:10950852 PMID:11442279 PMID:14557274 PMID:15104253 PMID:16003560 PMID:17256720 PMID:17599282 More...
|
|
NCBI chr 9:88,801,344...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a6 |
UDP glucuronosyltransferase family 1 member A6 |
affects glucuronidation |
ISO |
UGT1A6 protein affects the glucuronidation of chrysin |
CTD |
PMID:10950852 |
|
NCBI chr 9:88,747,213...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a7c |
UDP glucuronosyltransferase 1 family, polypeptide A7C |
increases glucuronidation |
EXP |
UGT1A7 protein results in increased glucuronidation of chrysin; UGT1A8 protein results in increased glucuronidation of chrysin |
CTD |
PMID:15502008 |
|
NCBI chr 9:88,739,577...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Ugt1a9 |
UDP glucuronosyltransferase family 1 member A9 |
increases glucuronidation affects glucuronidation |
ISO |
UGT1A9 protein results in increased glucuronidation of chrysin UGT1A9 protein affects the glucuronidation of chrysin |
CTD |
PMID:10950852 PMID:14557274 |
|
NCBI chr 9:88,696,981...88,808,465
Ensembl chr 9:88,713,184...88,808,465
|
|
G |
Utrn |
utrophin |
increases expression |
ISO |
chrysin results in increased expression of UTRN mRNA |
CTD |
PMID:22028826 |
|
NCBI chr 1:6,720,854...7,224,313
Ensembl chr 1:6,722,594...7,224,313
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
increases expression multiple interactions |
ISO |
chrysin results in increased expression of VCAM1 mRNA chrysin inhibits the reaction [TNF protein results in increased expression of VCAM1 protein] |
CTD |
PMID:16987811 PMID:18457675 |
|
NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
|
|
G |
Vegfa |
vascular endothelial growth factor A |
decreases expression multiple interactions |
ISO EXP |
chrysin results in decreased expression of VEGFA protein chrysin inhibits the reaction [alpha-naphthyl thiourea results in increased expression of VEGFA mRNA] |
CTD |
PMID:30578657 PMID:30974023 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vim |
vimentin |
decreases expression |
ISO |
chrysin results in decreased expression of VIM protein |
CTD |
PMID:24122885 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
G |
Xiap |
X-linked inhibitor of apoptosis |
decreases expression multiple interactions |
ISO |
chrysin results in decreased expression of XIAP protein BCL2 protein inhibits the reaction [chrysin results in decreased expression of XIAP protein] |
CTD |
PMID:16215670 |
|
NCBI chr X:120,890,537...120,938,413
Ensembl chr X:120,897,907...120,934,700
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
multiple interactions |
ISO |
5,7-dimethoxyflavone inhibits the reaction [ABCB1 protein results in decreased uptake of Daunorubicin]; 5,7-dimethoxyflavone inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]; 5,7-dimethoxyflavone inhibits the reaction [Elacridar inhibits the reaction [ABCB1 protein results in decreased uptake of Rhodamine 123]] |
CTD |
PMID:34217736 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
EXP |
[5,7-dimethoxyflavone co-treated with Diethylnitrosamine] results in increased expression of BAX protein |
CTD |
PMID:21554863 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2l1 |
Bcl2-like 1 |
multiple interactions |
EXP |
5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2L1 protein] |
CTD |
PMID:21554863 |
|
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
EXP |
5,7-dimethoxyflavone promotes the reaction [Diethylnitrosamine results in increased expression of CASP3 protein] |
CTD |
PMID:21554863 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions |
ISO |
5,7-dimethoxyflavone inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein] |
CTD |
PMID:24134915 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions |
EXP |
5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine results in increased expression of CCND1 mRNA]; 5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine results in increased expression of CCND1 protein] |
CTD |
PMID:21554863 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Csnk2b |
casein kinase 2 beta |
multiple interactions |
EXP |
5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine results in increased expression of CSNK2B mRNA]; 5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine results in increased expression of CSNK2B protein] |
CTD |
PMID:21554863 |
|
NCBI chr20:3,700,363...3,705,331
Ensembl chr20:3,698,733...3,707,133
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions |
EXP |
5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine affects the localization of CTNNB1 protein modified form]; 5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine results in increased expression of CTNNB1 mRNA] |
CTD |
PMID:21554863 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions decreases activity |
ISO |
5,7-dimethoxyflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of and results in increased activity of CYP1A1 protein]; 5,7-dimethoxyflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 mRNA]; 5,7-dimethoxyflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1A1 protein] 5,7-dimethoxyflavone results in decreased activity of CYP1A1 protein |
CTD |
PMID:15661813 PMID:15905203 PMID:16484233 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
multiple interactions decreases activity |
ISO |
5,7-dimethoxyflavone inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1B1 protein]; 5,7-dimethoxyflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 mRNA]; 5,7-dimethoxyflavone inhibits the reaction [Benzo(a)pyrene results in increased expression of CYP1B1 protein] 5,7-dimethoxyflavone results in decreased activity of CYP1B1 protein |
CTD |
PMID:15905203 PMID:16484233 PMID:16530937 |
|
NCBI chr 6:15,342,312...15,350,886
Ensembl chr 6:15,342,344...15,350,917
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
multiple interactions |
EXP |
5,7-dimethoxyflavone promotes the reaction [Diethylnitrosamine results in increased phosphorylation of GSK3B protein] |
CTD |
PMID:21554863 |
|
NCBI chr11:62,498,997...62,648,665
Ensembl chr11:62,504,316...62,648,646
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
5,7-dimethoxyflavone inhibits the reaction [IL1B protein results in increased secretion of CCL2 protein]; 5,7-dimethoxyflavone inhibits the reaction [IL1B protein results in increased secretion of CXCL8 protein]; 5,7-dimethoxyflavone inhibits the reaction [IL1B protein results in increased secretion of IL6 protein] |
CTD |
PMID:24134915 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
5,7-dimethoxyflavone inhibits the reaction [IL1B protein results in increased secretion of IL6 protein] |
CTD |
PMID:24134915 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
EXP |
5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine results in increased expression of NOS2 protein] |
CTD |
PMID:21554863 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
EXP |
5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine results in increased expression of PTGS2 mRNA]; 5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine results in increased expression of PTGS2 protein] |
CTD |
PMID:21554863 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP |
5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine results in increased expression of RELA mRNA]; 5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine results in increased expression of RELA protein modified form] |
CTD |
PMID:21554863 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions |
EXP |
[5,7-dimethoxyflavone co-treated with Diethylnitrosamine] results in increased expression of TP53 mRNA; [5,7-dimethoxyflavone co-treated with Diethylnitrosamine] results in increased expression of TP53 protein |
CTD |
PMID:21554863 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Wnt3a |
Wnt family member 3A |
multiple interactions |
EXP |
5,7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine results in increased expression of WNT3A protein] |
CTD |
PMID:21554863 |
|
NCBI chr10:44,034,174...44,078,366
Ensembl chr10:44,034,194...44,078,324
|
|
|
G |
Lcp1 |
lymphocyte cytosolic protein 1 |
multiple interactions |
ISO |
KT 5926 inhibits the reaction [calyculin A results in increased phosphorylation of LCP1 protein]; KT 5926 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of LCP1 protein] |
CTD |
PMID:14769871 |
|
NCBI chr15:50,443,300...50,544,682
Ensembl chr15:50,488,149...50,544,680
|
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
decreases expression affects localization |
EXP ISO |
ML 7 results in decreased expression of ACTA2 ML 7 affects the localization of ACTA2 protein |
CTD |
PMID:11591817 PMID:11868461 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO |
ML 7 results in decreased susceptibility to [quinocetone results in increased phosphorylation of AKT1 protein] |
CTD |
PMID:26446980 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
ISO |
[ML 7 co-treated with quinocetone] results in increased expression of BAX protein; ML 7 results in increased susceptibility to [quinocetone results in increased expression of BAX protein] |
CTD |
PMID:26446980 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcar1 |
BCAR1 scaffold protein, Cas family member |
decreases phosphorylation |
ISO |
ML 7 results in decreased phosphorylation of BCAR1 protein |
CTD |
PMID:18718759 |
|
NCBI chr19:39,679,215...39,713,907
Ensembl chr19:39,679,204...39,713,907
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions |
ISO |
[ML 7 co-treated with quinocetone] results in decreased expression of BCL2 protein; ML 7 results in increased susceptibility to [quinocetone results in decreased expression of BCL2 protein] |
CTD |
PMID:26446980 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
decreases expression |
ISO |
ML 7 results in decreased expression of BIRC5 protein |
CTD |
PMID:18710790 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
[ML 7 co-treated with quinocetone] results in increased cleavage of CASP3 protein; [ML 7 results in decreased activity of MYLK protein] which results in increased activity of CASP3 protein; FADD protein affects the reaction [[ML 7 results in decreased activity of MYLK protein] which results in increased activity of CASP3 protein] |
CTD |
PMID:16723733 PMID:26446980 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
multiple interactions |
ISO |
[ML 7 co-treated with quinocetone] results in increased cleavage of CASP8 protein; ML 7 results in increased susceptibility to [quinocetone results in increased cleavage of CASP8 protein] |
CTD |
PMID:26446980 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
ISO |
[ML 7 co-treated with quinocetone] results in increased cleavage of CASP9 protein; ML 7 results in increased susceptibility to [quinocetone results in increased cleavage of CASP9 protein] |
CTD |
PMID:26446980 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Ccna2 |
cyclin A2 |
multiple interactions |
EXP |
ML 7 inhibits the reaction [EGF protein results in increased expression of CCNA2 protein] |
CTD |
PMID:16799973 |
|
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions decreases expression |
EXP ISO |
ML 7 inhibits the reaction [EGF protein results in increased expression of CCND1 mRNA]; ML 7 inhibits the reaction [EGF protein results in increased expression of CCND1 protein] ML 7 results in decreased expression of CCND1 protein |
CTD |
PMID:16799973 PMID:18710790 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccne1 |
cyclin E1 |
multiple interactions |
EXP |
ML 7 inhibits the reaction [EGF protein results in increased expression of CCNE1 protein] |
CTD |
PMID:16799973 |
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Cdh1 |
cadherin 1 |
decreases activity affects localization |
ISO |
ML 7 results in decreased activity of CDH1 protein ML 7 affects the localization of CDH1 protein |
CTD |
PMID:16030252 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdk1 |
cyclin-dependent kinase 1 |
multiple interactions |
EXP |
ML 7 inhibits the reaction [EGF protein results in increased expression of CDK1 protein] |
CTD |
PMID:16799973 |
|
NCBI chr20:19,266,226...19,281,417
Ensembl chr20:19,266,248...19,281,408
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
decreases expression |
ISO |
ML 7 results in decreased expression of CDKN1A protein |
CTD |
PMID:15252113 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
increases expression |
ISO |
ML 7 results in increased expression of CDKN1B protein |
CTD |
PMID:15252113 |
|
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
|
|
G |
Col17a1 |
collagen type XVII alpha 1 chain |
affects localization |
ISO |
ML 7 affects the localization of COL17A1 protein |
CTD |
PMID:14691950 |
|
NCBI chr 1:246,530,589...246,577,559
Ensembl chr 1:246,531,367...246,577,632
|
|
G |
Csf2 |
colony stimulating factor 2 |
affects activity |
ISO |
ML 7 affects the activity of CSF2 protein |
CTD |
PMID:8471626 |
|
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Ctnnb1 |
catenin beta 1 |
affects localization decreases expression |
ISO |
ML 7 affects the localization of CTNNB1 protein ML 7 results in decreased expression of CTNNB1 protein |
CTD |
PMID:18710790 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Cxcl12 |
C-X-C motif chemokine ligand 12 |
multiple interactions |
ISO |
ML 7 inhibits the reaction [CXCL12 protein results in increased phosphorylation of MYL9 protein] |
CTD |
PMID:11751986 |
|
NCBI chr 4:150,388,326...150,401,173
Ensembl chr 4:150,388,325...150,401,168
|
|
G |
Dst |
dystonin |
affects localization |
ISO |
ML 7 affects the localization of DST protein |
CTD |
PMID:14691950 |
|
NCBI chr 9:36,135,657...36,529,617
Ensembl chr 9:36,135,284...36,529,615
|
|
G |
Egf |
epidermal growth factor |
multiple interactions |
EXP |
ML 7 inhibits the reaction [EGF protein affects the localization of MYL9 protein modified form]; ML 7 inhibits the reaction [EGF protein results in increased expression of CCNA2 protein]; ML 7 inhibits the reaction [EGF protein results in increased expression of CCND1 mRNA]; ML 7 inhibits the reaction [EGF protein results in increased expression of CCND1 protein]; ML 7 inhibits the reaction [EGF protein results in increased expression of CCNE1 protein]; ML 7 inhibits the reaction [EGF protein results in increased expression of CDK1 protein]; ML 7 inhibits the reaction [EGF protein results in increased expression of FOS protein]; ML 7 inhibits the reaction [EGF protein results in increased expression of JUN protein]; ML 7 inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] |
CTD |
PMID:16799973 |
|
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
|
|
G |
F2 |
coagulation factor II, thrombin |
multiple interactions decreases activity affects activity |
ISO EXP |
ML 7 inhibits the reaction [F2 protein results in increased phosphorylation of MYL9 protein] [ML 7 results in decreased activity of MYLK protein] which results in decreased activity of F2 protein ML 7 affects the activity of F2 protein |
CTD |
PMID:1643115 PMID:14557824 PMID:15284075 PMID:16675616 |
|
NCBI chr 3:77,596,196...77,609,486
Ensembl chr 3:77,596,198...77,609,486
|
|
G |
Fadd |
Fas associated via death domain |
multiple interactions |
ISO |
FADD protein affects the reaction [[ML 7 results in decreased activity of MYLK protein] which results in increased activity of CASP3 protein] |
CTD |
PMID:16723733 |
|
NCBI chr 1:199,743,200...199,745,746
Ensembl chr 1:199,739,994...199,745,653
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
ML 7 inhibits the reaction [EGF protein results in increased expression of FOS protein] |
CTD |
PMID:16799973 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Hexb |
hexosaminidase subunit beta |
multiple interactions |
EXP |
ML 7 inhibits the reaction [Ionomycin results in increased secretion of HEXB protein] |
CTD |
PMID:14499669 |
|
NCBI chr 2:28,483,997...28,504,165
Ensembl chr 2:28,484,012...28,504,223
|
|
G |
Il17a |
interleukin 17A |
multiple interactions |
ISO |
ML 7 inhibits the reaction [IL17A protein results in increased phosphorylation of MYL9 protein] |
CTD |
PMID:19940258 |
|
NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
|
|
G |
Itga3 |
integrin subunit alpha 3 |
multiple interactions |
ISO |
ML 7 affects the localization of [ITGA3 protein binds to ITGB1 protein] |
CTD |
PMID:14691950 |
|
NCBI chr10:79,990,160...80,022,206
Ensembl chr10:79,990,161...80,022,118
|
|
G |
Itga6 |
integrin subunit alpha 6 |
multiple interactions |
ISO |
ML 7 affects the localization of [ITGA6 protein binds to ITGB4 protein] |
CTD |
PMID:14691950 |
|
NCBI chr 3:56,604,512...56,689,428
Ensembl chr 3:56,617,268...56,689,428
|
|
G |
Itgam |
integrin subunit alpha M |
multiple interactions |
ISO |
ML 7 inhibits the reaction [Lipopolysaccharides results in increased expression of ITGAM protein] |
CTD |
PMID:19374788 |
|
NCBI chr 1:182,659,047...182,709,501
Ensembl chr 1:182,659,000...182,709,503
|
|
G |
Itgb1 |
integrin subunit beta 1 |
multiple interactions decreases activity |
ISO |
ML 7 affects the localization of [ITGA3 protein binds to ITGB1 protein] ML 7 results in decreased activity of ITGB1 protein |
CTD |
PMID:14691950 PMID:16723733 |
|
NCBI chr19:56,705,123...56,753,199
Ensembl chr19:56,705,171...56,753,195
|
|
G |
Itgb4 |
integrin subunit beta 4 |
multiple interactions |
ISO |
ML 7 affects the localization of [ITGA6 protein binds to ITGB4 protein] |
CTD |
PMID:14691950 |
|
NCBI chr10:101,206,657...101,243,012
Ensembl chr10:101,206,665...101,243,012
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
ML 7 inhibits the reaction [EGF protein results in increased expression of JUN protein] |
CTD |
PMID:16799973 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Lama3 |
laminin subunit alpha 3 |
affects localization |
ISO |
ML 7 affects the localization of LAMA3 protein |
CTD |
PMID:14691950 |
|
NCBI chr18:3,523,168...3,751,722
Ensembl chr18:3,523,133...3,751,353
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
decreases phosphorylation multiple interactions |
ISO |
ML 7 results in decreased phosphorylation of MAPK1 protein [ML 7 co-treated with quinocetone] results in increased phosphorylation of MAPK1 protein; ML 7 results in increased susceptibility to [quinocetone results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:18710790 PMID:26446980 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
multiple interactions |
ISO |
[ML 7 co-treated with quinocetone] results in increased phosphorylation of MAPK14 protein; ML 7 results in increased susceptibility to [quinocetone results in increased phosphorylation of MAPK14 protein] |
CTD |
PMID:26446980 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
decreases phosphorylation |
ISO |
ML 7 results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:18710790 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
ISO |
[ML 7 co-treated with quinocetone] results in increased phosphorylation of MAPK8 protein |
CTD |
PMID:26446980 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions decreases activity |
EXP ISO |
ML 7 inhibits the reaction [Lipopolysaccharides results in increased activity of MPO protein] ML 7 results in decreased activity of MPO protein |
CTD |
PMID:15863634 PMID:19374788 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
decreases expression |
ISO |
ML 7 results in decreased expression of MYC protein |
CTD |
PMID:18710790 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Myh2 |
myosin heavy chain 2 |
affects localization decreases activity |
ISO |
ML 7 affects the localization of MYH2 protein ML 7 results in decreased activity of MYH2 protein |
CTD |
PMID:16030252 |
|
NCBI chr10:51,856,738...51,883,236
Ensembl chr10:51,856,738...51,883,236
|
|
G |
Myl7 |
myosin light chain 7 |
multiple interactions decreases phosphorylation |
ISO |
ML 7 inhibits the reaction [Phenylephrine results in increased phosphorylation of MYL7 protein] ML 7 results in decreased phosphorylation of MYL7 protein |
CTD |
PMID:15621049 |
|
NCBI chr14:80,780,684...80,783,259
Ensembl chr14:80,779,776...80,783,244
|
|
G |
Myl9 |
myosin light chain 9 |
multiple interactions decreases phosphorylation decreases expression |
ISO EXP |
[ML 7 results in decreased activity of MYLK protein] which results in decreased phosphorylation of MYL9 protein; ML 7 inhibits the reaction [CXCL12 protein results in increased phosphorylation of MYL9 protein]; ML 7 inhibits the reaction [F2 protein results in increased phosphorylation of MYL9 protein]; ML 7 inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MYL9 protein] ML 7 results in decreased phosphorylation of MYL9 protein ML 7 inhibits the reaction [IL17A protein results in increased phosphorylation of MYL9 protein] [[ML 7 results in decreased activity of MYLK protein] which results in decreased phosphorylation of MYL9 protein] which results in increased secretion of REN protein; [ML 7 results in decreased activity of MYLK protein] which results in decreased phosphorylation of MYL9 protein; ML 7 inhibits the reaction [Deamino Arginine Vasopressin results in increased phosphorylation of MYL9 protein]; ML 7 inhibits the reaction [EGF protein affects the localization of MYL9 protein modified form]; ML 7 inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of MYL9 protein] ML 7 results in decreased expression of MYL9 protein modified form |
CTD |
PMID:1643115 PMID:7503253 PMID:9618396 PMID:11751986 PMID:12745062 PMID:15284075 PMID:15347643 PMID:15863634 PMID:16799973 PMID:17138966 PMID:17272349 PMID:17914957 PMID:18710790 PMID:18835913 PMID:19525378 PMID:19940258 PMID:19943851 More...
|
|
NCBI chr 3:145,281,943...145,288,333
Ensembl chr 3:145,281,937...145,288,333
|
|
G |
Mylk |
myosin light chain kinase |
multiple interactions decreases activity |
ISO EXP |
[ML 7 results in decreased activity of MYLK protein] which results in decreased phosphorylation of MYL9 protein; [ML 7 results in decreased activity of MYLK protein] which results in increased activity of CASP3 protein; FADD protein affects the reaction [[ML 7 results in decreased activity of MYLK protein] which results in increased activity of CASP3 protein]; ML 7 inhibits the reaction [Calcium deficiency results in increased activity of MYLK protein]; ML 7 inhibits the reaction [Ethanol results in increased activity of MYLK protein] [[ML 7 results in decreased activity of MYLK protein] which results in decreased phosphorylation of MYL9 protein] which results in increased secretion of REN protein; [ML 7 results in decreased activity of MYLK protein] which results in decreased phosphorylation of MYL9 protein ML 7 inhibits the reaction [Lipopolysaccharides results in increased expression of MYLK mRNA]; ML 7 inhibits the reaction [Lipopolysaccharides results in increased expression of MYLK protein]; ML 7 inhibits the reaction [MYLK protein results in increased uptake of Glucose] [ML 7 results in decreased activity of MYLK protein] which results in decreased activity of F2 protein; ML 7 results in decreased activity of MYLK protein |
CTD |
PMID:1643115 PMID:9618396 PMID:10198341 PMID:10733514 PMID:11054866 PMID:12534346 PMID:16675616 PMID:16723733 PMID:17541957 PMID:18773891 PMID:18835913 PMID:19374788 PMID:19943851 More...
|
|
NCBI chr11:65,783,008...66,030,239
Ensembl chr11:65,783,008...66,030,261
|
|
G |
Myod1 |
myogenic differentiation 1 |
decreases expression |
ISO |
ML 7 results in decreased expression of MYOD1 protein |
CTD |
PMID:15252113 |
|
NCBI chr 1:96,884,864...96,887,574
Ensembl chr 1:96,884,948...96,887,554
|
|
G |
Myog |
myogenin |
decreases expression |
ISO |
ML 7 results in decreased expression of MYOG protein |
CTD |
PMID:15252113 |
|
NCBI chr13:45,745,455...45,748,044
Ensembl chr13:45,745,436...45,748,039
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
multiple interactions |
ISO |
ML 7 inhibits the reaction [Tetradecanoylphorbol Acetate affects the localization of NCF1 protein]; ML 7 inhibits the reaction [Tetradecanoylphorbol Acetate results in increased phosphorylation of NCF1 protein] |
CTD |
PMID:7575484 |
|
NCBI chr12:22,485,382...22,494,647
Ensembl chr12:22,485,451...22,494,646
|
|
G |
Prkcb |
protein kinase C, beta |
decreases expression |
EXP |
ML 7 results in decreased expression of PRKCB protein |
CTD |
PMID:17272349 |
|
NCBI chr 1:176,832,173...177,163,539
Ensembl chr 1:176,832,226...177,163,536
|
|
G |
Ptk2 |
protein tyrosine kinase 2 |
decreases phosphorylation |
ISO |
ML 7 results in decreased phosphorylation of PTK2 protein |
CTD |
PMID:18718759 |
|
NCBI chr 7:105,126,725...105,331,848
Ensembl chr 7:105,126,728...105,331,783
|
|
G |
Rac1 |
Rac family small GTPase 1 |
decreases activity increases activity |
EXP |
ML 7 results in decreased activity of RAC1 protein ML 7 results in increased activity of RAC1 protein |
CTD |
PMID:12105187 PMID:12745062 |
|
NCBI chr12:11,037,028...11,057,251
Ensembl chr12:11,036,698...11,057,251
|
|
G |
Ren |
renin |
multiple interactions increases secretion |
EXP |
[[ML 7 results in decreased activity of MYLK protein] which results in decreased phosphorylation of MYL9 protein] which results in increased secretion of REN protein; calyculin A inhibits the reaction [ML 7 results in increased secretion of REN protein]; ML 7 inhibits the reaction [Calcium results in decreased secretion of REN protein] |
CTD |
PMID:9618396 |
|
NCBI chr13:44,796,260...44,807,491
Ensembl chr13:44,796,091...44,807,489
|
|
G |
Rps6ka5 |
ribosomal protein S6 kinase A5 |
decreases activity |
ISO |
ML 7 results in decreased activity of RPS6KA5 protein |
CTD |
PMID:12534346 |
|
NCBI chr 6:119,828,823...120,006,190
Ensembl chr 6:119,828,846...120,006,224
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
multiple interactions |
EXP ISO |
ML 7 inhibits the reaction [EGF protein results in increased phosphorylation of and results in increased activity of RPS6KB1 protein] ML 7 results in decreased susceptibility to [quinocetone results in increased phosphorylation of RPS6KB1 protein] |
CTD |
PMID:16799973 PMID:26446980 |
|
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
|
|
G |
Slc2a2 |
solute carrier family 2 member 2 |
multiple interactions decreases activity decreases expression |
EXP |
ML 7 inhibits the reaction [SLC2A2 protein results in increased uptake of Glucose] ML 7 results in decreased activity of SLC2A2 protein ML 7 results in decreased expression of SLC2A2 protein |
CTD |
PMID:17272349 |
|
NCBI chr 2:111,609,798...111,639,930
Ensembl chr 2:111,611,774...111,639,933
|
|
G |
Tjp1 |
tight junction protein 1 |
multiple interactions |
ISO |
ML 7 inhibits the reaction [Oxygen deficiency affects the localization of TJP1 protein] ML 7 inhibits the reaction [Luteolin inhibits the reaction [decabromobiphenyl ether results in decreased expression of TJP1 protein]] |
CTD |
PMID:20164382 PMID:33675858 |
|
NCBI chr 1:118,849,838...119,094,492
Ensembl chr 1:118,849,838...119,094,432
|
|
G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
decreases activity |
ISO |
ML 7 results in decreased activity of TRPC6 protein |
CTD |
PMID:17603544 |
|
NCBI chr 8:5,759,387...5,864,000
Ensembl chr 8:5,758,935...5,828,092
|
|
G |
Trpc7 |
transient receptor potential cation channel, subfamily C, member 7 |
increases activity |
ISO |
ML 7 results in increased activity of TRPC7 protein |
CTD |
PMID:17603544 |
|
NCBI chr17:7,708,911...7,833,435
Ensembl chr17:7,709,583...7,833,435
|
|